Tarsus Pharmaceuticals (TARS)'s 30-day implied volatility (IV30) was 62.2% at the close on November 2, 2026, down from 76.3% the day before, against a 52-week range of 33.0% to 77.9%. Its 20-day historical volatility was 44.8%.
Data as of November 2, 2026.